Related Experiment Video
Updated: Dec 30, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular disease in patients with chronic kidney disease
Turgay Saritas1, Jürgen Floege2
1Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Germany. tsaritas@ukaachen.de.
Insights
Patients with chronic kidney disease (CKD) face higher risks of cardiovascular disease (CVD) and death than kidney failure. Managing CVD in advanced CKD presents unique challenges due to limited trial data.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Patients with chronic kidney disease (CKD) have a significantly elevated risk of cardiovascular disease (CVD) and mortality.
- Cardiovascular disease mortality in CKD patients often surpasses the risk of progressing to end-stage renal disease.
- Managing comorbidities like CVD in advanced CKD is complex, partly because these patients are frequently excluded from clinical trials.
Purpose of the Study:
- To review the epidemiology, risk factors, and clinical presentations of CVD in individuals with advanced CKD.
- To highlight the specific diagnostic and therapeutic challenges associated with heart failure, coronary artery disease, and atrial fibrillation in this population.
Main Methods:
- This is a review article.
- Literature search and synthesis of existing evidence on CVD in advanced CKD.
Main Results:
- Advanced CKD is strongly associated with increased CVD risk and mortality.
- Specific CVD conditions like heart failure, coronary artery disease, and atrial fibrillation pose distinct management difficulties in CKD patients.
- Understanding the epidemiology and risk factors is crucial for clinical decision-making.
Conclusions:
- CVD is a major cause of morbidity and mortality in patients with advanced CKD.
- There is a critical need for improved diagnostic and therapeutic strategies tailored to CKD patients.
- Further research and clinical trial inclusion are necessary to address evidence gaps in managing CVD in advanced CKD.
Abstract:
Patients with chronic kidney disease (CKD) are at increased risk for kidney failure, cardiovascular disease (CVD), and death. In fact, the likelihood of dying from CVD is markedly higher than that for reaching end-stage renal disease. Evidence-based management of comorbidities such as CVD remains challenging in patients with advanced CKD, as they were usually excluded from randomized controlled trials. This review focuses on the epidemiology, risk factors, and clinical manifestations of CVD in patients with advanced CKD. Specific topics of interest include diagnostic and therapeutic challenges of heart failure, coronary artery disease, and atrial fibrillation.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention

